Pacific Biosciences

$30.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.57 (-12.80%) Today

-$0.35 (-1.11%) As of 1:40 PM UTC after-hours

Why Robinhood?

You can buy or sell PACB and other stocks, options, and ETFs commission-free!

About PACB

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. The listed name for PACB is Pacific Biosciences of California, Inc. Common Stock.

CEO

Christian O. Henry

Employees

404

Headquarters

Menlo Park, California

Founded

2000

Market Cap

6.25B

Price-Earnings Ratio

210.29

Dividend Yield

—

Average Volume

7.28M

High Today

$35.68

Low Today

$30.52

Open Price

$35.68

Volume

7.09M

52 Week High

$53.69

52 Week Low

$2.20

PACB News

BenzingaFeb 24

SoftBank-Backed Ride-Hailing Company Didi Beefs Up Europe Entry Plan

Bloomberg (Bloomberg) -- SoftBank Group Corp. plans to expand its investments in the biotech and health-care sector, opening up a new front in its growing asse

PACB Earnings

-$0.19

-$0.00

$0.18

$0.37

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours